Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 7496647)

1.

The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales.

Sugarman MA, Loree AM, Baltes BB, Grekin ER, Kirsch I.

PLoS One. 2014 Aug 27;9(8):e106337. doi: 10.1371/journal.pone.0106337. eCollection 2014.

2.

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.

3.

Nonpharmacological treatments for anxiety disorders.

Cottraux J.

Dialogues Clin Neurosci. 2002 Sep;4(3):305-19.

4.

PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLD.

Salvi R, Lobarinas E, Sun W.

Drugs Future. 2009;34(5):381-400.

5.

Venlafaxine in the treatment of panic disorder.

Katzman MA, Jacobs L.

Neuropsychiatr Dis Treat. 2007 Feb;3(1):59-67.

6.

Pharmacotherapy of panic disorder.

Pull CB, Damsa C.

Neuropsychiatr Dis Treat. 2008 Aug;4(4):779-95.

7.

Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions.

Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, Smith SM, Dawson DA, Pulay AJ, Pickering RP, Ruan WJ.

J Clin Psychiatry. 2008 Apr;69(4):533-45.

8.

Three year naturalistic outcome study of panic disorder patients treated with paroxetine.

Dannon PN, Iancu I, Cohen A, Lowengrub K, Grunhaus L, Kotler M.

BMC Psychiatry. 2004 Jun 11;4:16.

9.

Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.

Black K, Shea C, Dursun S, Kutcher S.

J Psychiatry Neurosci. 2000 May;25(3):255-61. Review.

10.

Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.

Leinonen E, Lepola U, Koponen H, Turtonen J, Wade A, Lehto H.

J Psychiatry Neurosci. 2000 Jan;25(1):24-32.

11.

Antidepressant discontinuation reactions.

Haddad P, Lejoyeux M, Young A.

BMJ. 1998 Apr 11;316(7138):1105-6. No abstract available.

12.

Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators.

Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M.

Heart. 1997 Dec;78(6):581-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk